In addition, we found that the NaHCO3-enhanced therapeutic efficiency of PD-L1 was accompanied by the induction of an effector CD8+ T cell response and the increased accumulation of IFN-γ + CD8+ T cells within the tumor. The gene discussed is CD8A; the disease is neoplasm.